{"parse":{"title":"Antimicrobial stewardship","pageid":45624709,"revid":845013485,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Antimicrobial stewardship</b> (AMS) is the systematic effort to educate and persuade prescribers of <a href=\"/wiki/Antimicrobial\" title=\"Antimicrobial\">antimicrobials</a> to follow <a href=\"/wiki/Evidence-based_medicine\" title=\"Evidence-based medicine\">evidence-based</a> prescribing, in order to stem <a href=\"/wiki/Antibiotic_misuse\" title=\"Antibiotic misuse\">antibiotic overuse</a>, and thus <a href=\"/wiki/Antimicrobial_resistance\" title=\"Antimicrobial resistance\">antimicrobial resistance</a><sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>. AMS has been an organized effort of <a href=\"/wiki/Specialty_(medicine)\" title=\"Specialty (medicine)\">specialists</a> in <a href=\"/wiki/Infectious_diseases\" class=\"mw-redirect\" title=\"Infectious diseases\">infectious diseases</a>, both in Internal Medicine and Pediatrics with their respective peer-organizations, <a href=\"/wiki/Hospital_pharmacy\" title=\"Hospital pharmacy\">hospital pharmacists</a>,  the <a href=\"/wiki/Public_health\" title=\"Public health\">public health</a> community and their professional organizations since the late 1990s. It has first been implemented in hospitals. In the U.S., within the context of physicians' prescribing freedom (choice of <a href=\"/wiki/Prescription_drug\" title=\"Prescription drug\">prescription drugs</a>), AMS has largely been voluntary <a href=\"/wiki/Self-control\" title=\"Self-control\">self-regulation</a> in the form of policies and appeals to adhere to a prescribing self-discipline. At hospitals, this may take the form of an antimicrobial stewardship program. As of 2014, only the state of California has made this type of AMS mandatory by law. Within the context of commercial and <a href=\"/wiki/Over-the-counter_drug\" title=\"Over-the-counter drug\">over-the-counter</a> use of antimicrobials, legally mandated AMS has begun with <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">FDA</a> rules that <a href=\"/wiki/Triclosan\" title=\"Triclosan\">triclosan</a> be phased out of consumer-grade <a href=\"/wiki/Soap\" title=\"Soap\">soaps</a> due to lack of good evidence that such use improves <a href=\"/wiki/Public_health\" title=\"Public health\">public health</a>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Definition_and_goals\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Definition and goals</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#History\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Locations\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Locations</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Participants\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Participants</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Program_components\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Program components</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Baseline_assessment\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Baseline assessment</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Goals_of_desirable_antimicrobial_use\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Goals of desirable antimicrobial use</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Interventions_on_antimicrobial_prescribing\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Interventions on antimicrobial prescribing</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Provide_feedback,_continuing_education\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Provide feedback, continuing education</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Interventions\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Interventions</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Outcomes_to_measure\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Outcomes to measure</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#Controversies\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Controversies</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#See_also\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-14\"><a href=\"#References\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#External_links\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Definition_and_goals\">Definition and goals</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=1\" title=\"Edit section: Definition and goals\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The 2007 definition by the Society for Healthcare Epidemiology of America (SHEA) defines AMS as a \"set of coordinated strategies to improve the use of antimicrobial medications with the goal to \n</p>\n<ul><li>enhance patient health <a href=\"/wiki/Outcomes_research\" title=\"Outcomes research\">outcomes</a>,</li>\n<li>reduce <a href=\"/wiki/Antibiotic_resistance\" class=\"mw-redirect\" title=\"Antibiotic resistance\">antibiotic resistance</a>, and</li>\n<li>decrease unnecessary costs\".<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup></li></ul>\n<p>Decreasing the overuse of antimicrobials is expected to serve the following goals:\n</p>\n<ul><li>improve patient outcomes, especially <a href=\"/wiki/Patient_safety\" title=\"Patient safety\">patient safety</a></li>\n<li>decrease <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">adverse drug reactions</a> such as hypersensitivity reactions or kidney or heart damage (e.g., QT prolongation).</li>\n<li>decrease antibiotic-associated disease, such as <a href=\"/wiki/Clostridium_difficile_infection\" title=\"Clostridium difficile infection\"><i>Clostridium difficile</i>\u2013associated diarrhea</a>, other <a href=\"/wiki/Antibiotic-associated_diarrhea\" title=\"Antibiotic-associated diarrhea\">antibiotic-associated diarrheas</a>, and <a href=\"/wiki/Invasive_Candidiasis\" class=\"mw-redirect\" title=\"Invasive Candidiasis\">invasive candidiasis</a></li>\n<li>guard the patient's <a href=\"/wiki/Human_microbiota\" title=\"Human microbiota\">microbiome</a>, including the <a href=\"/wiki/Gut_flora\" title=\"Gut flora\">gut flora</a>, respiratory tract flora, <a href=\"/wiki/Vaginal_flora\" title=\"Vaginal flora\">urogenital tract flora</a>, and <a href=\"/wiki/Skin_flora\" title=\"Skin flora\">skin flora</a> (this is closely related to the preceding goal of preventing antibiotic-associated disease)</li>\n<li>decrease wasted costs</li>\n<li>slow the increase in <a href=\"/wiki/Antimicrobial_resistance\" title=\"Antimicrobial resistance\">antimicrobial resistance</a></li>\n<li>prevent unforeseen <a href=\"/wiki/Environmental_degradation\" title=\"Environmental degradation\">environmental degradation</a>, such as likely adverse effects of altering <a href=\"/wiki/Biota_(ecology)\" class=\"mw-redirect\" title=\"Biota (ecology)\">biotas</a> and animal <a href=\"/wiki/Microbiota\" title=\"Microbiota\">microbiotas</a> by pervading the <a href=\"/wiki/Water_cycle\" title=\"Water cycle\">water cycle</a> with antimicrobials in <a href=\"/wiki/Wastewater\" title=\"Wastewater\">wastewater</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=2\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Antimicrobial misuse was recognized as early as the 1940s, when <a href=\"/wiki/Alexander_Fleming\" title=\"Alexander Fleming\">Alexander Fleming</a> remarked on penicillin's decreasing efficacy, because of its <a href=\"/wiki/Antibiotic_misuse\" title=\"Antibiotic misuse\">overuse</a>.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p>In 1966, the first systematic assessment of antibiotic use in the <a href=\"/wiki/Winnipeg\" title=\"Winnipeg\">Winnipeg</a>, Manitoba, Canada general hospital was published: Medical records were reviewed during two non-consecutive four-month periods (medicine, psychiatry, urology, gynecology and surgery, orthopedics, neurosurgery, ear, nose and throat, and ophthalmology). Information was coded on <a href=\"/wiki/Punched_card\" title=\"Punched card\">punched cards</a> using 78 columns.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\nOthers in 1968 estimated that 50% of antimicrobial use was either unnecessary or inappropriate <sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> This figure is likely the lower end of the estimate, and continues to be referenced as of 2015.\n</p><p>In the 1970s the first <a href=\"/wiki/Clinical_pharmacy\" title=\"Clinical pharmacy\">clinical pharmacy</a> services were established in North American hospitals. The first formal evaluation of antibiotic use in children regarding antibiotic choice, dose and necessity of treatment was undertaken at <a href=\"/wiki/The_Children%27s_Hospital_of_Winnipeg\" title=\"The Children&#39;s Hospital of Winnipeg\">The Children's Hospital of Winnipeg</a>. Researchers observed errors in therapy in 30% of medical orders and 63% of surgical orders.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>  The most frequent error was unnecessary treatment found in 13% of medical and 45% of surgical orders. The authors stated \"Many find it difficult to accept that there are standards against which therapy may be judged.\"\n</p><p>In the 1980s the antibiotic class of <a href=\"/wiki/Cephalosporins\" class=\"mw-redirect\" title=\"Cephalosporins\">cephalosporins</a> was introduced, further increasing bacterial resistance. During this decade <a href=\"/wiki/Infection_control\" title=\"Infection control\">infection control</a> programs began to be established in hospitals, which systematically recorded and investigated hospital-acquired infections. Evidence-based treatment guidelines and regulation of antibiotic use surfaced. Australian researchers published the first <a href=\"/wiki/Medical_guideline\" title=\"Medical guideline\">medical guideline</a> <a href=\"/wiki/Outcomes_research\" title=\"Outcomes research\">outcomes research</a>.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2015)\">citation needed</span></a></i>&#93;</sup>\n</p><p>The term AMS was coined in 1996 by two <a href=\"/wiki/Internist\" class=\"mw-redirect\" title=\"Internist\">internists</a> at <a href=\"/wiki/Emory_University_School_of_Medicine\" title=\"Emory University School of Medicine\">Emory University School of Medicine</a>, John McGowan and Dale Gerding, a specialist on <a href=\"/wiki/C._difficile\" class=\"mw-redirect\" title=\"C. difficile\">C. difficile</a>. They suggested \"...large-scale, well-controlled trials of antimicrobial use regulation employing sophisticated epidemiologic methods, molecular biological organism typing, and precise resistance mechanism analysis [...] to determine the best methods to prevent and control this problem [antimicrobial resistance] and ensure our optimal antimicrobial use stewardship\" and that \"...the long-term effects of antimicrobial selection, dosage, and duration of treatment on resistance development should be a part of every antimicrobial treatment decision.\"<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p><p>In 1997, SHEA and the <a href=\"/wiki/Infectious_Diseases_Society_of_America\" title=\"Infectious Diseases Society of America\">Infectious Diseases Society of America</a> published guidelines to prevent antimicrobial resistance arguing that \"\u2026appropriate antimicrobial stewardship, that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms.\" <sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p><p>Ten years later, in 2007, bacterial, antiviral and antifungal resistance had risen to such a degree that the <a href=\"/wiki/Centers_for_Disease_Control_and_Prevention\" title=\"Centers for Disease Control and Prevention\">CDC</a> rang the alarm<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2015)\">citation needed</span></a></i>&#93;</sup>. The same year, IDSA and SHEA published guidelines for developing an AMS program.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>  Also in 2007, the first pediatric publication used the term AMS.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>A survey of pediatric infectious disease consultants in 2008 by the Emerging Infectious Disease Network revealed that only 45 (33%) respondents had an AMS program, mostly from before 2000, and another 25 (18%) planned an ASP (data unpublished).\n</p><p>In 2012, the SHEA, IDSA and PIDS published a joint policy statement on AMS.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p><p>The CDC's NHSN has been monitoring antimicrobial use and resistance in hospitals that volunteer to provide data.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p><p>In 2014, the CDC recommended, that all US hospitals have an antibiotic stewardship program.<sup id=\"cite_ref-cdc14_13-0\" class=\"reference\"><a href=\"#cite_note-cdc14-13\">&#91;13&#93;</a></sup>\n</p><p>The <a href=\"/wiki/Joint_Commission\" title=\"Joint Commission\">Joint Commission</a> has approved regulations which go into effect January 1, 2017 detailing that hospitals should have an Antimicrobial Stewardship team consisting of Infection preventionist(s), Pharmacist(s), and a Practitioner to write protocols and develop projects focused on the appropriate use of antibiotics.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Locations\">Locations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=3\" title=\"Edit section: Locations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>AMS is needed wherever antimicrobials are prescribed in human medicine, namely in hospitals, outpatient clinics, and long term care institutions, including hospice.\n</p><p>Guidelines for prudent or judicious use in veterinary medicine have been developed by the Canadian Veterinary Medicine Association in 2008.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> A particular problem is that veterinarians are both prescribers and dispensers. Regulators and the veterinary community in the European Union have been discussing the separation of these activities.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Participants\">Participants</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=4\" title=\"Edit section: Participants\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Antimicrobial stewardship focuses on prescribers, be it <a href=\"/wiki/Physician\" title=\"Physician\">physician</a>, <a href=\"/wiki/Physician_assistant\" title=\"Physician assistant\">physician assistant</a>, <a href=\"/wiki/Nurse_practitioner\" title=\"Nurse practitioner\">nurse practitioner</a>, on the prescription and the microorganism, if any. At a hospital, AMS can be organized in the form of an AMS committee that meets monthly. The day-to-day work is done by a core group, usually an infectious disease physician, who may or may not serve in hospital epidemiology and infection control, or/ and a pharmacist, ideally but rarely aided by an information technologist. The entire committee may include physician representatives, who are top antimicrobial prescribers such as physicians in <a href=\"/wiki/Intensive_care_medicine\" title=\"Intensive care medicine\">intensive care medicine</a>, <a href=\"/wiki/Hematology\" title=\"Hematology\">Hematology</a> -<a href=\"/wiki/Oncology\" title=\"Oncology\">Oncology</a>, <a href=\"/wiki/Cystic_fibrosis\" title=\"Cystic fibrosis\">cystic fibrosis</a> clinicians or <a href=\"/wiki/Hospitalist\" class=\"mw-redirect\" title=\"Hospitalist\">hospitalists</a>, a <a href=\"/wiki/Microbiologist\" title=\"Microbiologist\">microbiologist</a>, a <a href=\"/wiki/Quality_management\" title=\"Quality management\">quality improvement (QI)</a> specialist, and a representative from hospital administration.\n</p><p>For an AMS program to be established the institution has to recognize its value. In the US it has become customary to present a <a href=\"/wiki/Business_plan\" title=\"Business plan\">business plan</a> to the executive officers of the hospital administration.\n</p>\n<h2><span class=\"mw-headline\" id=\"Program_components\">Program components</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=5\" title=\"Edit section: Program components\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>As of 2014, thirteen internet-based institutional ASP resources in US academic medical centers had been published.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> An AMS program has the following tasks, in line with <a href=\"/wiki/Quality_improvement\" class=\"mw-redirect\" title=\"Quality improvement\">quality improvement</a> theory:\n</p>\n<h3><span class=\"mw-headline\" id=\"Baseline_assessment\">Baseline assessment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=6\" title=\"Edit section: Baseline assessment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Parts of the baseline assessment are to:\n</p>\n<ul><li>Measure baseline antimicrobial use, dosing, duration, costs and use patterns.</li>\n<li>Study type of microbial isolates, susceptibilities, and trends thereof</li>\n<li>Identify clinician indications for prescriptions.</li></ul>\n<p>In hospitals and clinics using electronic medical records, information technology resources are crucial to hone in on these questions. As of 2015, commercial computer surveillance software programs for microbiology and antimicrobial administrations appear to outnumber \"homegrown\" institutional programs, and include, but are not limited to TREAT Steward, TheraDoc, Sentri7, and Vigilanz.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Goals_of_desirable_antimicrobial_use\">Goals of desirable antimicrobial use</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=7\" title=\"Edit section: Goals of desirable antimicrobial use\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>For the desired antimicrobial use, goals need to be formulated:\n</p>\n<ul><li>Define \"appropriate\", rational antimicrobial use for the institution, individual patient units, and define empiric treatment versus culture-directed antimicrobial treatment.</li>\n<li>Establish treatment guidelines for clinical syndromes. These can be disseminated in the form of memos, in-services or grand rounds and may be most effective in the form of decision making tools at the point of ordering the prescription.</li></ul>\n<h3><span class=\"mw-headline\" id=\"Interventions_on_antimicrobial_prescribing\">Interventions on antimicrobial prescribing</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=8\" title=\"Edit section: Interventions on antimicrobial prescribing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The actual interventions on antimicrobial prescribing consist of numerous elements\n</p>\n<h3><span id=\"Provide_feedback.2C_continuing_education\"></span><span class=\"mw-headline\" id=\"Provide_feedback,_continuing_education\">Provide feedback, continuing education</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=9\" title=\"Edit section: Provide feedback, continuing education\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<ul><li>Survey prescriber knowledge about antibiotics, antifungal or antiviral drugs.</li>\n<li>Provide targeted education about particular antibiotics, or one specific antimicrobial at a time, as well as empiric treatment for syndromes versus culture directed treatment.</li>\n<li>Assist in making duration more visible to prescribers. Some institutions use automatic stop orders.</li>\n<li>Decreasing diagnostic uncertainty by appropriate testing, including rapid diagnostic methods. The most effective strategy to decrease diagnostic uncertainty would be to align the focus with other safety projects, and QI measures (e.g. blood management, adverse effects etc.).</li></ul>\n<p>Biomerieux has published case studies of countries that introduced AMS.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Interventions\">Interventions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=10\" title=\"Edit section: Interventions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The day-to-day work of the core AMS members is to screen patients' <a href=\"/wiki/Medical_records\" class=\"mw-redirect\" title=\"Medical records\">medical records</a> for some of the following questions, in order of importance:\n</p>\n<ul><li>Appropriate antimicrobial choice based on susceptibility, avoiding redundance&#160;?</li>\n<li>Appropriate dose (mg/kg dosing in children)&#160;?</li>\n<li>Appropriate dosing interval according to age, weight and renal function or <a href=\"/wiki/Drug-drug_interaction\" class=\"mw-redirect\" title=\"Drug-drug interaction\">drug-drug interaction</a>?</li>\n<li>Appropriate deescalation of antimicrobials after culture results are final&#160;?</li>\n<li>Appropriate administration route and feasibility of drug conversion from intravenous to by mouth (PO)?</li></ul>\n<p>If the answer is no, the team needs to effectively communicate a recommendation, which may be in person or in the medical record.\n</p><p>Further tasks are:\n</p>\n<ul><li>Automatic review of the medical record after 72h empiric use, culture results, other laboratory data</li>\n<li>Advise on appropriate duration of antimicrobial therapy</li>\n<li>Annual report to administration, calculation of cost savings if any.</li></ul>\n<h2><span class=\"mw-headline\" id=\"Outcomes_to_measure\">Outcomes to measure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=11\" title=\"Edit section: Outcomes to measure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Two pediatric infectious disease physicians have suggested to look at the following variables to judge the outcome of AMS interventions:<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> \n</p>\n<ul><li>Annual pharmacy acquisition costs</li>\n<li>Antibiotic days/1,000 patient days</li>\n<li>Identifying \"drug-bug mismatches\"</li>\n<li>IV to oral conversion</li>\n<li>Optimal dosing</li>\n<li>Stopping redundant therapy</li>\n<li>Reducing adverse events</li>\n<li>Overall compliance with ASP recommendations</li></ul>\n<p>When examining the relationship between an outcome and an intervention, the epidemiological method of <a href=\"/wiki/Time_series_analysis\" class=\"mw-redirect\" title=\"Time series analysis\">time series analysis</a> is preferred, because it accounts for the dependence between time points.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (March 2015)\">citation needed</span></a></i>&#93;</sup>\nA recent global stewardship survey identified barriers to the initiation, development and implementation of stewardship programmes internationally.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Controversies\">Controversies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=12\" title=\"Edit section: Controversies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>At this time the optimal metrics to benchmark antimicrobial use are still controversial.</li>\n<li>To measure unit of antimicrobials consumed, one can use 'Days Of Therapy' (DOT) or <a href=\"/wiki/Defined_Daily_Dose\" class=\"mw-redirect\" title=\"Defined Daily Dose\">Defined Daily Dose</a> (DDD). The former is more commonly used in the US, the latter is more commonly used in Europe.</li>\n<li>Data source for the use: The electronic medication administration record (eMAR) is the most accurate correlate for doses given, but may be difficult to analyze, because of hold orders and patient refusal, as opposed to administrative or billing data, that may be easier to obtain.</li>\n<li>The question of \"appropriateness of use\" is probably the most controversial. Appropriate use depends on the local antimicrobial resistance profile and therefore has different regional answers. Merely the \"amount\" of antibiotics used is no straightforward metric for appropriateness.</li>\n<li>In regard to the most effective AMS intervention, the answer will depend on the size of the institution and the resources available: The system of \"prior approval\" of antimicrobials by infectious diseases has been used first historically. It is very time- and labor-intensive, and prescribers do not like its restrictive character. Increasingly \"post-prescription review\" is used.</li>\n<li>Although education consistently shows improvement in participants' knowledge and attitudes, the results do not always translate to better practice.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup></li></ul>\n<p>It can be difficult to decide if a clinical syndrome or a particular drug should be targeted for interventions and education. \nHow to best modify prescriber behavior has been the subject of controversy and research. At issue is how feedback is presented to prescribers, individually, in aggregate, with or without peer comparisons, and whether to reward or punish. \nAs long as the best quality metrics for an AMS program are unknown, a combination of antimicrobial consumption, antimicrobial resistance, and antimicrobial and drug resistant organism related mortality are used.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=13\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Antibiotic_resistance\" class=\"mw-redirect\" title=\"Antibiotic resistance\">antibiotic resistance</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=14\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://animalantibiotics.org/dig-deeper/industry-glossary/\">\"Industry Glossary\"</a>. <i>Animal Antibiotics</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-06-08</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Animal+Antibiotics&amp;rft.atitle=Industry+Glossary&amp;rft_id=https%3A%2F%2Fanimalantibiotics.org%2Fdig-deeper%2Findustry-glossary%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Dellit TH;  et al. (1 January 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20140525023140/http://www.shea-online.org/View/ArticleId/9/Guidelines-for-Developing-an-Institutional-Program-to-Enhance-Antimicrobial-Stewardship.aspx\">\"Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship\"</a>. SHEA. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.shea-online.org/View/ArticleId/9/Guidelines-for-Developing-an-Institutional-Program-to-Enhance-Antimicrobial-Stewardship.aspx\">the original</a> on 25 May 2014<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 November</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guidelines+for+Developing+an+Institutional+Program+to+Enhance+Antimicrobial+Stewardship&amp;rft.pub=SHEA&amp;rft.date=2007-01-01&amp;rft.au=Dellit+TH&amp;rft_id=http%3A%2F%2Fwww.shea-online.org%2FView%2FArticleId%2F9%2FGuidelines-for-Developing-an-Institutional-Program-to-Enhance-Antimicrobial-Stewardship.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">\"Fleming, Alexander: The Penicillin Finder Assays its Future\". <i>The New York Times</i>. 25 June 1945. p.&#160;21.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Fleming%2C+Alexander%3A+The+Penicillin+Finder+Assays+its+Future&amp;rft.pages=21&amp;rft.date=1945-06-25&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ruedy, J. (1966). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1935763\">\"A method of determining patterns of use of antibacterial drugs\"</a>. <i>Can Med Assoc J</i>. <b>95</b> (16): :807\u201312. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1935763\">1935763</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/5928520\">5928520</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Can+Med+Assoc+J&amp;rft.atitle=A+method+of+determining+patterns+of+use+of+antibacterial+drugs.&amp;rft.volume=95&amp;rft.issue=16&amp;rft.pages=%3A807-12&amp;rft.date=1966&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1935763&amp;rft_id=info%3Apmid%2F5928520&amp;rft.aulast=Ruedy&amp;rft.aufirst=J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1935763&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Reimann; D\u2019Ambola (1968). \"Cost of antimicrobial drugs in a hospital\". <i>JAMA</i>. <b>205</b>: 537. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.205.7.537\">10.1001/jama.205.7.537</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/5695313\">5695313</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Cost+of+antimicrobial+drugs+in+a+hospital.&amp;rft.volume=205&amp;rft.pages=537&amp;rft.date=1968&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.205.7.537&amp;rft_id=info%3Apmid%2F5695313&amp;rft.au=Reimann&amp;rft.au=D%E2%80%99Ambola&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Schollenberg, E.; Albritton WL (1980). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1801611\">\"Antibiotic misuse in a pediatric teaching hospital\"</a>. <i>Can Med Assoc J</i>. <b>122</b> (1): 49\u201352. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1801611\">1801611</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7363195\">7363195</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Can+Med+Assoc+J&amp;rft.atitle=Antibiotic+misuse+in+a+pediatric+teaching+hospital.&amp;rft.volume=122&amp;rft.issue=1&amp;rft.pages=49-52&amp;rft.date=1980&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1801611&amp;rft_id=info%3Apmid%2F7363195&amp;rft.aulast=Schollenberg&amp;rft.aufirst=E.&amp;rft.au=Albritton+WL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1801611&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">McGowan, JE Jr; Gerding, DN (August 1996). \"Does antibiotic restriction prevent resistance?\". <i>New Horizon</i>. <b>4</b> (3): 370\u20136. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8856755\">8856755</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+Horizon&amp;rft.atitle=Does+antibiotic+restriction+prevent+resistance%3F&amp;rft.volume=4&amp;rft.issue=3&amp;rft.pages=370-6&amp;rft.date=1996-08&amp;rft_id=info%3Apmid%2F8856755&amp;rft.aulast=McGowan&amp;rft.aufirst=JE+Jr&amp;rft.au=Gerding%2C+DN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shlaes, D;  et al. (April 1997). \"Guidelines for the prevention of antimicrobial resistance in hospitals\". <i>Infect Control Hosp Epidemiol</i>. <b>18</b>: 275\u201391. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9131374\">9131374</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infect+Control+Hosp+Epidemiol.&amp;rft.atitle=Guidelines+for+the+prevention+of+antimicrobial+resistance+in+hospitals.&amp;rft.volume=18&amp;rft.pages=275-91&amp;rft.date=1997-04&amp;rft_id=info%3Apmid%2F9131374&amp;rft.aulast=Shlaes&amp;rft.aufirst=D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dellit, TH; Owens, RC; McGowan, JE Jr; Gerding, DN; Weinstein, RA; Burke, JP; Huskins, WC; Paterson, DL; Fishman, NO; Carpenter, CF; Brennan, PJ; Billeter, M; Hooton, TM (2007). \"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship\". <i>Clin Infect Dis</i>. <b>44</b>: 159\u2013177. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1086/510393\">10.1086/510393</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17173212\">17173212</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Infect+Dis&amp;rft.atitle=Infectious+Diseases+Society+of+America+and+the+Society+for+Healthcare+Epidemiology+of+America+guidelines+for+developing+an+institutional+program+to+enhance+antimicrobial+stewardship.&amp;rft.volume=44&amp;rft.pages=159-177&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1086%2F510393&amp;rft_id=info%3Apmid%2F17173212&amp;rft.aulast=Dellit&amp;rft.aufirst=TH&amp;rft.au=Owens%2C+RC&amp;rft.au=McGowan%2C+JE+Jr&amp;rft.au=Gerding%2C+DN&amp;rft.au=Weinstein%2C+RA&amp;rft.au=Burke%2C+JP&amp;rft.au=Huskins%2C+WC&amp;rft.au=Paterson%2C+DL&amp;rft.au=Fishman%2C+NO&amp;rft.au=Carpenter%2C+CF&amp;rft.au=Brennan%2C+PJ&amp;rft.au=Billeter%2C+M&amp;rft.au=Hooton%2C+TM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Patel, SJ; Larson EL; Kubin CJ; Saiman L (June 2007). \"A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations\". <i>Pediatr Infect Dis J</i>. <b>26</b> (6): 531\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/inf.0b013e3180593170\">10.1097/inf.0b013e3180593170</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17529873\">17529873</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatr+Infect+Dis+J&amp;rft.atitle=A+review+of+antimicrobial+control+strategies+in+hospitalized+and+ambulatory+pediatric+populations&amp;rft.volume=26&amp;rft.issue=6&amp;rft.pages=531-7&amp;rft.date=2007-06&amp;rft_id=info%3Adoi%2F10.1097%2Finf.0b013e3180593170&amp;rft_id=info%3Apmid%2F17529873&amp;rft.aulast=Patel&amp;rft.aufirst=SJ&amp;rft.au=Larson+EL&amp;rft.au=Kubin+CJ&amp;rft.au=Saiman+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Society for Healthcare Epidemiology of America; Infectious Diseases Society of America; Pediatric Infectious Diseases Society. (April 2012). \"Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)\". <i>Infect Ctrl Hosp Epidemiol</i>. <b>33</b>: 322\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1086/665010\">10.1086/665010</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22418625\">22418625</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infect+Ctrl+Hosp+Epidemiol&amp;rft.atitle=Policy+statement+on+antimicrobial+stewardship+by+the+Society+for+Healthcare+Epidemiology+of+America+%28SHEA%29%2C+the+Infectious+Diseases+Society+of+America+%28IDSA%29%2C+and+the+Pediatric+Infectious+Diseases+Society+%28PIDS%29.&amp;rft.volume=33&amp;rft.pages=322-7&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1086%2F665010&amp;rft_id=info%3Apmid%2F22418625&amp;rft.au=Society+for+Healthcare+Epidemiology+of+America&amp;rft.au=Infectious+Diseases+Society+of+America&amp;rft.au=Pediatric+Infectious+Diseases+Society.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">HICPAC (March 2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.cste.org/resource/dynamic/forums/20130319_111419_15786.pdf\">\"Updates on NHSN Monitoring of Antimicrobial Use and Resistance\"</a> <span style=\"font-size:85%;\">(PDF)</span><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">1 June</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Updates+on+NHSN+Monitoring+of+Antimicrobial+Use+and+Resistance&amp;rft.date=2013-03&amp;rft.au=HICPAC&amp;rft_id=http%3A%2F%2Fwww.cste.org%2Fresource%2Fdynamic%2Fforums%2F20130319_111419_15786.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-cdc14-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-cdc14_13-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Loria A. Pollack, Arjun Srinivasan (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://cid.oxfordjournals.org/content/59/suppl_3/S97.full\">\"Core Elements of Hospital Antibiotic Stewardship Programs From the Centers for Disease Control and Prevention\"</a>. <i>Clin Infect Dis</i>. <b>59</b> (suppl 3): S97\u2013S100. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/cid/ciu542\">10.1093/cid/ciu542</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 March</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Infect+Dis&amp;rft.atitle=Core+Elements+of+Hospital+Antibiotic+Stewardship+Programs+From+the+Centers+for+Disease+Control+and+Prevention&amp;rft.volume=59&amp;rft.issue=suppl+3&amp;rft.pages=S97-S100&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fciu542&amp;rft.au=Loria+A.+Pollack%2C+Arjun+Srinivasan&amp;rft_id=http%3A%2F%2Fcid.oxfordjournals.org%2Fcontent%2F59%2Fsuppl_3%2FS97.full&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation magazine\">Joint Commission (July 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.jointcommission.org/assets/1/6/New_Antimicrobial_Stewardship_Standard.pdf\">\"New Antimicrobial Stewardship Standard\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Joint Commission Perspectives</i>. Vol.&#160;36 no.&#160;7.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=New+Antimicrobial+Stewardship+Standard&amp;rft.date=2016-07&amp;rft.au=Joint+Commission&amp;rft_id=https%3A%2F%2Fwww.jointcommission.org%2Fassets%2F1%2F6%2FNew_Antimicrobial_Stewardship_Standard.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">CVMA (2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.canadianveterinarians.net/documents/canadian-veterinary-medical-association-antimicrobial-prudent-use-guidelines-2008-for-beef-cattle-dairy-cattle-poultry-and-swine.\">\"CVMA Prudent Use Guidelines 2008 for beef cattle, dairy cattle, poultry, and swine\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CVMA+Prudent+Use+Guidelines+2008+for+beef+cattle%2C+dairy+cattle%2C+poultry%2C+and+swine&amp;rft.date=2008&amp;rft.au=CVMA&amp;rft_id=http%3A%2F%2Fwww.canadianveterinarians.net%2Fdocuments%2Fcanadian-veterinary-medical-association-antimicrobial-prudent-use-guidelines-2008-for-beef-cattle-dairy-cattle-poultry-and-swine.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">\"Federation of Veterinarians of Europe (FVE) concerned about separating antimicrobial prescribing and supply\". <i>Vet Rec</i>. <b>15</b> (171(24)): 609. December 2012. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/vr.e8348\">10.1136/vr.e8348</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vet+Rec.&amp;rft.atitle=Federation+of+Veterinarians+of+Europe+%28FVE%29+concerned+about+separating+antimicrobial+prescribing+and+supply&amp;rft.volume=15&amp;rft.issue=171%2824%29&amp;rft.pages=609&amp;rft.date=2012-12&amp;rft_id=info%3Adoi%2F10.1136%2Fvr.e8348&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Timothy P. Gauthier; Evan Lantz; Alexander Heyliger; Sarah M. Francis; Laura Smith (2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://cid.oxfordjournals.org/content/early/2013/11/07/cid.cit705.full#ref-1\">\"Internet-Based Institutional Antimicrobial Stewardship Program Resources in Leading US Academic Medical Centers\"</a>. <i>Clinical Infectious Diseases</i>. <b>58</b> (3): 445\u2013446. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/cid/cit705\">10.1093/cid/cit705</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24170198\">24170198</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Infectious+Diseases&amp;rft.atitle=Internet-Based+Institutional+Antimicrobial+Stewardship+Program+Resources+in+Leading+US+Academic+Medical+Centers&amp;rft.volume=58&amp;rft.issue=3&amp;rft.pages=445-446&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fcit705&amp;rft_id=info%3Apmid%2F24170198&amp;rft.au=Timothy+P.+Gauthier&amp;rft.au=Evan+Lantz&amp;rft.au=Alexander+Heyliger&amp;rft.au=Sarah+M.+Francis&amp;rft.au=Laura+Smith&amp;rft_id=http%3A%2F%2Fcid.oxfordjournals.org%2Fcontent%2Fearly%2F2013%2F11%2F07%2Fcid.cit705.full%23ref-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jason G. Newland; Jeffrey S. Gerber; Scott J. Weissman; Samir S. Shah; Chelsea Turgeon; Erin B. Hedican; Cary Thurm; Matt Hall; Joshua Courter; Thomas V. Brogan; Holly Maples; Brian R. Lee; Adam L. Hersh (March 2014). \"Prevalence and Characteristics of Antimicrobial Stewardship Programs at Freestanding Children's Hospitals in the United States\". <i>Infection Control and Hospital Epidemiology</i>. <b>35</b> (3): 265\u2013271. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1086/675277\">10.1086/675277</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24521592\">24521592</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infection+Control+and+Hospital+Epidemiology&amp;rft.atitle=Prevalence+and+Characteristics+of+Antimicrobial+Stewardship+Programs+at+Freestanding+Children%E2%80%99s+Hospitals+in+the+United+States.&amp;rft.volume=35&amp;rft.issue=3&amp;rft.pages=265-271&amp;rft.date=2014-03&amp;rft_id=info%3Adoi%2F10.1086%2F675277&amp;rft_id=info%3Apmid%2F24521592&amp;rft.au=Jason+G.+Newland&amp;rft.au=Jeffrey+S.+Gerber&amp;rft.au=Scott+J.+Weissman&amp;rft.au=Samir+S.+Shah&amp;rft.au=Chelsea+Turgeon&amp;rft.au=Erin+B.+Hedican&amp;rft.au=Cary+Thurm&amp;rft.au=Matt+Hall&amp;rft.au=Joshua+Courter&amp;rft.au=Thomas+V.+Brogan&amp;rft.au=Holly+Maples&amp;rft.au=Brian+R.+Lee&amp;rft.au=Adam+L.+Hersh&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.biomerieux-diagnostics.com/sites/clinic/files/be_smart_newsletter_n6.pdf\">Be SMART with Resistance</a>, Biomerieux, Intern. Newsletter October 2013, 8 pp</span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Newland, Jason; Adam Hersh (2010). \"Purpose and design of antimicrobial stewardship programs in pediatrics\". <i>Pediatr Infect Dis J</i>. <b>29</b>: 862\u2013863. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/INF.0b013e3181ef2507\">10.1097/INF.0b013e3181ef2507</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20720473\">20720473</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatr+Infect+Dis+J&amp;rft.atitle=Purpose+and+design+of+antimicrobial+stewardship+programs+in+pediatrics.&amp;rft.volume=29&amp;rft.pages=862-863.&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1097%2FINF.0b013e3181ef2507&amp;rft_id=info%3Apmid%2F20720473&amp;rft.aulast=Newland&amp;rft.aufirst=Jason&amp;rft.au=Adam+Hersh&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\">Howard P. et al., ESCMID Study Group for Antimicrobial Policies (ESGAP) &amp; ISC. Group on Antimicrobial Stewardship ECCMID 2013, Berlin Presentation Nr. 24</span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yeung, Eugene Y. H.; Alexander, Megan. <a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/doi/10.1111/bcp.13375/abstract\">\"Use of junior doctor-led peer education to improve antibiotic stewardship\"</a>. <i>British Journal of Clinical Pharmacology</i>: n/a\u2013n/a. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/bcp.13375\">10.1111/bcp.13375</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1365-2125\">1365-2125</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.atitle=Use+of+junior+doctor-led+peer+education+to+improve+antibiotic+stewardship&amp;rft.pages=n%2Fa-n%2Fa&amp;rft_id=info%3Adoi%2F10.1111%2Fbcp.13375&amp;rft.issn=1365-2125&amp;rft.aulast=Yeung&amp;rft.aufirst=Eugene+Y.+H.&amp;rft.au=Alexander%2C+Megan&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fbcp.13375%2Fabstract&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">MacDougall, Conan; Schwartz, Brian S.; Kim, Lisa; Nanamori, Mari; Shekarchian, Sharmin; Chin-Hong, Peter V. (2017-01-01). <a rel=\"nofollow\" class=\"external text\" href=\"https://academic.oup.com/ofid/article/4/1/ofw225/2964768/An-Interprofessional-Curriculum-on-Antimicrobial\">\"An Interprofessional Curriculum on Antimicrobial Stewardship Improves Knowledge and Attitudes Toward Appropriate Antimicrobial Use and Collaboration\"</a>. <i>Open Forum Infectious Diseases</i>. <b>4</b> (1). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/ofid/ofw225\">10.1093/ofid/ofw225</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Open+Forum+Infectious+Diseases&amp;rft.atitle=An+Interprofessional+Curriculum+on+Antimicrobial+Stewardship+Improves+Knowledge+and+Attitudes+Toward+Appropriate+Antimicrobial+Use+and+Collaboration&amp;rft.volume=4&amp;rft.issue=1&amp;rft.date=2017-01-01&amp;rft_id=info%3Adoi%2F10.1093%2Fofid%2Fofw225&amp;rft.aulast=MacDougall&amp;rft.aufirst=Conan&amp;rft.au=Schwartz%2C+Brian+S.&amp;rft.au=Kim%2C+Lisa&amp;rft.au=Nanamori%2C+Mari&amp;rft.au=Shekarchian%2C+Sharmin&amp;rft.au=Chin-Hong%2C+Peter+V.&amp;rft_id=https%3A%2F%2Facademic.oup.com%2Fofid%2Farticle%2F4%2F1%2Fofw225%2F2964768%2FAn-Interprofessional-Curriculum-on-Antimicrobial&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Morris, Brener S, S (2012). \"Use of a structured panel process to define quality metrics for antimicrobial stewardship programs\". <i>Infect Ctrl Hosp Epidemiol</i>. <b>33</b>: 500\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1086/665324\">10.1086/665324</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22476277\">22476277</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infect+Ctrl+Hosp+Epidemiol&amp;rft.atitle=Use+of+a+structured+panel+process+to+define+quality+metrics+for+antimicrobial+stewardship+programs.&amp;rft.volume=33&amp;rft.pages=500-6&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1086%2F665324&amp;rft_id=info%3Apmid%2F22476277&amp;rft.aulast=Morris%2C+Brener+S&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAntimicrobial+stewardship\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Antimicrobial_stewardship&amp;action=edit&amp;section=15\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150318031303/http://www.shea-online.org/PriorityTopics/AntimicrobialStewardship/ImplementationToolsResources.aspx\">Antimicrobial Stewardship: Implementation Tools &amp; Resources</a> Society for Healthcare Epidemiology of America (SHEA)</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html\">Core Elements of Hospital Antibiotic Stewardship Programs</a> CDC</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cidrap.umn.edu/asp\">Antimicrobial Stewardship Project</a>, at the <a href=\"/wiki/Center_for_Infectious_Disease_Research_and_Policy\" title=\"Center for Infectious Disease Research and Policy\">Center for Infectious Disease Research and Policy</a> (CIDRAP), University of Minnesota</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.idsociety.org/Stewardship_Policy/#sthash.9hJvI8jd.dpuf\">Promoting Antimicrobial Stewardship in Human Medicine</a> Infectious Diseases Society of America (IDSA)</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/antimicrobial-resistance/global-action-plan/optimise-use/surveillance/en/\">Surveillance of antimicrobial use</a> WHO\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/drugresistance/events/Oslomeeting/en/\">Commitments to Responsible Use of Antimicrobials in Humans</a> WHO 13\u201314 November 2014</li></ul></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.tufts.edu/med/apua/\">Alliance for the Prudent Use of Antibiotics (APUA)</a>, Tufts University Boston, MA</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.noharm.org/us_canada/nurses/protect_antibiotics.php\">Protect Antibiotics Toolkit</a> Health Care Without Harm</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.sustainabletable.org/257/antibiotics\">Global Resource Action Center for the Environment (GRACE)</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150407115407/http://www.cspinet.org/foodsafety/abr.html\">Center for Science in the Public Interest</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://toxics.usgs.gov/highlights/bacteria_gw.html\">Antibiotics in Groundwater Change Bacterial Ecology</a> US Geological Survey, Toxic Substances Hydrology Program]</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.treatsystems.com\">Treat Systems</a> Example of a software tool supporting Antimicrobial Stewardship</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1324\nCached time: 20180908092442\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.308 seconds\nReal time usage: 0.355 seconds\nPreprocessor visited node count: 1506/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 49782/2097152 bytes\nTemplate argument size: 1531/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 30952/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.171/10.000 seconds\nLua memory usage: 4.05 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  299.866      1 -total\n 64.88%  194.539      1 Template:Reflist\n 30.67%   91.977      3 Template:Citation_needed\n 30.21%   90.596     16 Template:Cite_journal\n 22.52%   67.541      3 Template:Fix\n 18.16%   54.468      4 Template:Cite_web\n 12.91%   38.709      6 Template:Category_handler\n  7.57%   22.691      3 Template:Delink\n  2.19%    6.573      1 Template:Cite_news\n  1.72%    5.162      1 Template:Cite_magazine\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:45624709-0!canonical and timestamp 20180908092442 and revision id 845013485\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_March_2015"},{"sortkey":"","*":"Antibiotic_resistance"},{"sortkey":"","*":"Healthcare_quality"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from March 2015"},{"ns":0,"exists":"","*":"Adverse drug reaction"},{"ns":0,"exists":"","*":"Alexander Fleming"},{"ns":0,"exists":"","*":"Antibiotic-associated diarrhea"},{"ns":0,"exists":"","*":"Antibiotic misuse"},{"ns":0,"exists":"","*":"Antibiotic resistance"},{"ns":0,"exists":"","*":"Antimicrobial"},{"ns":0,"exists":"","*":"Antimicrobial resistance"},{"ns":0,"exists":"","*":"Biota (ecology)"},{"ns":0,"exists":"","*":"Business plan"},{"ns":0,"exists":"","*":"C. difficile"},{"ns":0,"exists":"","*":"Center for Infectious Disease Research and Policy"},{"ns":0,"exists":"","*":"Centers for Disease Control and Prevention"},{"ns":0,"exists":"","*":"Cephalosporins"},{"ns":0,"exists":"","*":"Clinical pharmacy"},{"ns":0,"exists":"","*":"Clostridium difficile infection"},{"ns":0,"exists":"","*":"Cystic fibrosis"},{"ns":0,"exists":"","*":"Defined Daily Dose"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Drug-drug interaction"},{"ns":0,"exists":"","*":"Emory University School of Medicine"},{"ns":0,"exists":"","*":"Environmental degradation"},{"ns":0,"exists":"","*":"Evidence-based medicine"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Gut flora"},{"ns":0,"exists":"","*":"Hematology"},{"ns":0,"exists":"","*":"Hospital pharmacy"},{"ns":0,"exists":"","*":"Hospitalist"},{"ns":0,"exists":"","*":"Human microbiota"},{"ns":0,"exists":"","*":"Infection control"},{"ns":0,"exists":"","*":"Infectious Diseases Society of America"},{"ns":0,"exists":"","*":"Infectious diseases"},{"ns":0,"exists":"","*":"Intensive care medicine"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Internist"},{"ns":0,"exists":"","*":"Invasive Candidiasis"},{"ns":0,"exists":"","*":"Joint Commission"},{"ns":0,"exists":"","*":"Medical guideline"},{"ns":0,"exists":"","*":"Medical records"},{"ns":0,"exists":"","*":"Microbiologist"},{"ns":0,"exists":"","*":"Microbiota"},{"ns":0,"exists":"","*":"Nurse practitioner"},{"ns":0,"exists":"","*":"Oncology"},{"ns":0,"exists":"","*":"Outcomes research"},{"ns":0,"exists":"","*":"Over-the-counter drug"},{"ns":0,"exists":"","*":"Patient safety"},{"ns":0,"exists":"","*":"Physician"},{"ns":0,"exists":"","*":"Physician assistant"},{"ns":0,"exists":"","*":"Prescription drug"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Public health"},{"ns":0,"exists":"","*":"Punched card"},{"ns":0,"exists":"","*":"Quality improvement"},{"ns":0,"exists":"","*":"Quality management"},{"ns":0,"exists":"","*":"Self-control"},{"ns":0,"exists":"","*":"Skin flora"},{"ns":0,"exists":"","*":"Soap"},{"ns":0,"exists":"","*":"Specialty (medicine)"},{"ns":0,"exists":"","*":"The Children's Hospital of Winnipeg"},{"ns":0,"exists":"","*":"Time series analysis"},{"ns":0,"exists":"","*":"Triclosan"},{"ns":0,"exists":"","*":"Vaginal flora"},{"ns":0,"exists":"","*":"Wastewater"},{"ns":0,"exists":"","*":"Water cycle"},{"ns":0,"exists":"","*":"Winnipeg"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"}],"templates":[{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite magazine"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["https://animalantibiotics.org/dig-deeper/industry-glossary/","https://web.archive.org/web/20140525023140/http://www.shea-online.org/View/ArticleId/9/Guidelines-for-Developing-an-Institutional-Program-to-Enhance-Antimicrobial-Stewardship.aspx","http://www.shea-online.org/View/ArticleId/9/Guidelines-for-Developing-an-Institutional-Program-to-Enhance-Antimicrobial-Stewardship.aspx","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1935763","//www.ncbi.nlm.nih.gov/pubmed/5928520","//doi.org/10.1001/jama.205.7.537","//www.ncbi.nlm.nih.gov/pubmed/5695313","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1801611","//www.ncbi.nlm.nih.gov/pubmed/7363195","//www.ncbi.nlm.nih.gov/pubmed/8856755","//www.ncbi.nlm.nih.gov/pubmed/9131374","//doi.org/10.1086/510393","//www.ncbi.nlm.nih.gov/pubmed/17173212","//doi.org/10.1097/inf.0b013e3180593170","//www.ncbi.nlm.nih.gov/pubmed/17529873","//doi.org/10.1086/665010","//www.ncbi.nlm.nih.gov/pubmed/22418625","http://www.cste.org/resource/dynamic/forums/20130319_111419_15786.pdf","http://cid.oxfordjournals.org/content/59/suppl_3/S97.full","//doi.org/10.1093/cid/ciu542","https://www.jointcommission.org/assets/1/6/New_Antimicrobial_Stewardship_Standard.pdf","http://www.canadianveterinarians.net/documents/canadian-veterinary-medical-association-antimicrobial-prudent-use-guidelines-2008-for-beef-cattle-dairy-cattle-poultry-and-swine.","//doi.org/10.1136/vr.e8348","http://cid.oxfordjournals.org/content/early/2013/11/07/cid.cit705.full#ref-1","//doi.org/10.1093/cid/cit705","//www.ncbi.nlm.nih.gov/pubmed/24170198","//doi.org/10.1086/675277","//www.ncbi.nlm.nih.gov/pubmed/24521592","http://www.biomerieux-diagnostics.com/sites/clinic/files/be_smart_newsletter_n6.pdf","//doi.org/10.1097/INF.0b013e3181ef2507","//www.ncbi.nlm.nih.gov/pubmed/20720473","http://onlinelibrary.wiley.com/doi/10.1111/bcp.13375/abstract","//doi.org/10.1111/bcp.13375","//www.worldcat.org/issn/1365-2125","https://academic.oup.com/ofid/article/4/1/ofw225/2964768/An-Interprofessional-Curriculum-on-Antimicrobial","//doi.org/10.1093/ofid/ofw225","//doi.org/10.1086/665324","//www.ncbi.nlm.nih.gov/pubmed/22476277","https://web.archive.org/web/20150318031303/http://www.shea-online.org/PriorityTopics/AntimicrobialStewardship/ImplementationToolsResources.aspx","https://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html","http://www.cidrap.umn.edu/asp","http://www.idsociety.org/Stewardship_Policy/#sthash.9hJvI8jd.dpuf","http://www.who.int/antimicrobial-resistance/global-action-plan/optimise-use/surveillance/en/","http://www.who.int/drugresistance/events/Oslomeeting/en/","http://www.tufts.edu/med/apua/","http://www.noharm.org/us_canada/nurses/protect_antibiotics.php","http://www.sustainabletable.org/257/antibiotics","https://web.archive.org/web/20150407115407/http://www.cspinet.org/foodsafety/abr.html","http://toxics.usgs.gov/highlights/bacteria_gw.html","http://www.treatsystems.com"],"sections":[{"toclevel":1,"level":"2","line":"Definition and goals","number":"1","index":"1","fromtitle":"Antimicrobial_stewardship","byteoffset":1591,"anchor":"Definition_and_goals"},{"toclevel":1,"level":"2","line":"History","number":"2","index":"2","fromtitle":"Antimicrobial_stewardship","byteoffset":3588,"anchor":"History"},{"toclevel":1,"level":"2","line":"Locations","number":"3","index":"3","fromtitle":"Antimicrobial_stewardship","byteoffset":11392,"anchor":"Locations"},{"toclevel":1,"level":"2","line":"Participants","number":"4","index":"4","fromtitle":"Antimicrobial_stewardship","byteoffset":12460,"anchor":"Participants"},{"toclevel":1,"level":"2","line":"Program components","number":"5","index":"5","fromtitle":"Antimicrobial_stewardship","byteoffset":13547,"anchor":"Program_components"},{"toclevel":2,"level":"3","line":"Baseline assessment","number":"5.1","index":"6","fromtitle":"Antimicrobial_stewardship","byteoffset":14245,"anchor":"Baseline_assessment"},{"toclevel":2,"level":"3","line":"Goals of desirable antimicrobial use","number":"5.2","index":"7","fromtitle":"Antimicrobial_stewardship","byteoffset":15517,"anchor":"Goals_of_desirable_antimicrobial_use"},{"toclevel":2,"level":"3","line":"Interventions on antimicrobial prescribing","number":"5.3","index":"8","fromtitle":"Antimicrobial_stewardship","byteoffset":16039,"anchor":"Interventions_on_antimicrobial_prescribing"},{"toclevel":2,"level":"3","line":"Provide feedback, continuing education","number":"5.4","index":"9","fromtitle":"Antimicrobial_stewardship","byteoffset":16172,"anchor":"Provide_feedback,_continuing_education"},{"toclevel":1,"level":"2","line":"Interventions","number":"6","index":"10","fromtitle":"Antimicrobial_stewardship","byteoffset":17097,"anchor":"Interventions"},{"toclevel":1,"level":"2","line":"Outcomes to measure","number":"7","index":"11","fromtitle":"Antimicrobial_stewardship","byteoffset":18061,"anchor":"Outcomes_to_measure"},{"toclevel":1,"level":"2","line":"Controversies","number":"8","index":"12","fromtitle":"Antimicrobial_stewardship","byteoffset":19287,"anchor":"Controversies"},{"toclevel":1,"level":"2","line":"See also","number":"9","index":"13","fromtitle":"Antimicrobial_stewardship","byteoffset":22445,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"10","index":"14","fromtitle":"Antimicrobial_stewardship","byteoffset":22486,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"11","index":"15","fromtitle":"Antimicrobial_stewardship","byteoffset":22519,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Antimicrobial stewardship","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q19903321"}]}}